You will be primarily responsible for planning and executing post-approval market launch strategies for companion diagnostic (CDx) systems, including Oncomine Dx Target Test (ODxTT) and Oncomine Dx Express Test (ODxET), for existing and new cancer types or biomarker additions.
Must-have
Nice-to-have
Not specified